eNauka - pregled
Pregled prema Projekat Novartis AG
Prikaz rezultata 1 do 3 od 3
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2026 | BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study | Weichenthal, Michael; ...; Popovic, Aleksandar; ...; (broj, koautora 31) | Article | Mp. category will be shown later |
| 2026 | Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study | Ellebaek, Eva; ...; Dujovic, Branko; ...; (broj, koautora 49) | Article | Mp. category will be shown later |
| 2022 | Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across Europe | Weichenthal, Michael; ...; Kandolf-Sekulovic, Lidija O; ...; (broj, koautora 20) | Conference Paper | Mp. category will be shown later |